Understanding undergraduate medicines optimisation education and its importance; a realist evaluation
Open Access
- 20 January 2026
- journal article
- Published by Ubiquity Press, Ltd. in Perspectives on Medical Education
- Vol. 15 (1) , 647-662
Abstract
Introduction Problematic polypharmacy (PP) is associated with risks and burdens for patients, and waste for healthcare systems. To overcome this challenge, clinicians must be able to tailor clinical decisions to patients’ individual circumstances by integrating biomedical with biographical accounts of illness. This skillset has not been well defined or taught. Medicines optimisation (MO) is a key clinical activity in tackling PP and can exemplify the practical wisdom required for this integration. How and why MO education works is poorly understood. Our previous work, a realist review of published interventions, addressed this gap by explaining how undergraduate MO education could work but was limited by the thin descriptions available. Here, we develop those findings by using primary data from interviews of expert educators to develop and refine our explanatory model. Methods This realist evaluation develops the programme theory from our review using primary data from individual realist interviews of MO experts. Realist configurational analysis was used. The study is conducted and reported in-keeping with RAMESES II standards. Results Sixteen experts in MO were interviewed; data were used to refine or refute our previous theorising. Analysis showed MO education which seeks to integrate interpretive practice into clinical decision-making must be valued by learners and be sufficiently aligned with educational and workplace culture to garner the engagement necessary to undertake this learning process. Learners must feel they have permission to practice interpretive medicine when healthcare structures are organised to the contrary. A perception of critical mass within a community of practice may facilitate the required security in decision-making for ongoing practice. Discussion We describe how and why undergraduate MO educational programmes can work to produce important outcomes in tackling the challenge of PP. We highlight how MO educational programmes may also act as practical gateways to routine interpretive practice in broader clinical areas.Keywords
This publication has 23 references indexed in Scilit:
- A Proposed Curricular Framework for an Interprofessional Approach to DeprescribingMedical Science Educator, 2023
- Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital AdmissionDrug Safety, 2022
- An Interprofessional Student‐Run Medication Review Program: The Clinical STOPP/START‐Based Outcomes of a Controlled Clinical Trial in a Geriatric Outpatient ClinicClinical Pharmacology & Therapeutics, 2021
- The clinical and educational outcomes of an inter-professional student-led medication review team, a pilot studyEuropean Journal of Clinical Pharmacology, 2020
- The Scottish Polypharmacy Guidance app in practicePrescriber, 2020
- Deprescribing: An educational imperativeResearch in Social and Administrative Pharmacy, 2019
- Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approachThe Lancet, 2018
- Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking actionEuropean Journal of Internal Medicine, 2017
- A novel approach to teaching pharmacotherapeutics—feasibility of the learner-centered student-run clinicEuropean Journal of Clinical Pharmacology, 2015
- Polypharmacy – appropriate, problematic or both?Prescriber, 2015